Association of type 2 diabetes susceptibility loci with one-year weight loss in the look AHEAD clinical trial

Obesity

Volumn 20, Issue 8, 2012, Pages 1675-1682

  Peter, Inga ^a   McCaffery, Jeanne M ^b   Kelley Hedgepeth, Alyson ^c   Hakonarson, Hakon ^d   Reis, Steven ^e   Wagenknecht, Lynne E ^f   Kopin, Alan S ^c   Huggins, Gondon S ^c  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b BROWN UNIVERSITY   (United States)

^c TUFTS MEDICAL CENTER   (United States)

^d CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^f WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALLELE; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; COHORT ANALYSIS; COMMUNITY LIVING; CONTROLLED STUDY; DIABETES CONTROL; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; IRS1 GENE; JAZF1 GENE; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MTNR1B GENE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POPULATION RESEARCH; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SUPPRESSOR GENE; TCF7L2 GENE; THERAPY EFFECT; TREATMENT DURATION; WAIST CIRCUMFERENCE; WEIGHT CHANGE; WEIGHT REDUCTION;

AGED; ALLELES; BODY MASS INDEX; CARDIOVASCULAR DISEASES; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INSULIN RECEPTOR SUBSTRATE PROTEINS; LIFE STYLE; MALE; MIDDLE AGED; NEOPLASM PROTEINS; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, MELATONIN, MT1; RISK; RISK FACTORS; TRANSCRIPTION FACTOR 7-LIKE 2 PROTEIN; WAIST CIRCUMFERENCE; WEIGHT LOSS; WEIGHT REDUCTION PROGRAMS;

EID: 84864351302     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2012.11     Document Type: Article

References (36)

1. Kannel WB, McGee DL. Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care 1979;2: 120-126.
2. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983;67:968-977.
3. Knowler WC, Barrett-Connor E, Fowler SE et al.; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403.
4. Maruthur NM, Wang NY, Appel LJ. Lifestyle interventions reduce coronary heart disease risk: results from the PREMIER Trial. Circulation 2009;119:2026-2031.
5. Wing RR, Koeske R, Epstein LH et al. Long-term effects of modest weight loss in type II diabetic patients. Arch Intern Med 1987;147:1749-1753.
6. Alexandrides TK, Skroubis G, Kalfarentzos F. Resolution of diabetes mellitus and metabolic syndrome following Roux-en-Y gastric bypass and a variant of biliopancreatic diversion in patients with morbid obesity. Obes Surg 2007;17:176-184.
7. Sladek R, Rocheleau G, Rung J et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007;445:881-885.
8. Zeggini E, Scott LJ, Saxena R et al.; Wellcome Trust Case Control Consortium. Meta-analysis of genome-wide association data and largescale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet 2008;40:638-645.
9. Voight BF, Scott LJ, Steinthorsdottir V et al.; MAGIC investigators; GIANT Consortium. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 2010;42:579-589.
10. Takeuchi F, Serizawa M, Yamamoto K et al. Confirmation of multiple risk Loci and genetic impacts by a genome-wide association study of type 2 diabetes in the Japanese population. Diabetes 2009;58:1690-1699.
11. Rung J, Cauchi S, Albrechtsen A et al. Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia. Nat Genet 2009;41:1110-1115.
12. Zeggini E, Weedon MN, Lindgren CM et al.; Wellcome Trust Case Control Consortium (WTCCC). Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 2007;316: 1336-1341.
13. Tan JT, Ng DP, Nurbaya S et al. Polymorphisms identified through genomewide association studies and their associations with type 2 diabetes in Chinese, Malays, and Asian-Indians in Singapore. J Clin Endocrinol Metab 2010;95:390-397.
14. Scott LJ, Mohlke KL, Bonnycastle LL et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 2007;316:1341-1345.
15. Sim X, Ong RT, Suo C et al. Transferability of type 2 diabetes implicated loci in multi-ethnic cohorts from Southeast Asia. PLoS Genet 2011;7:e1001363.
16. Steinthorsdottir V, Thorleifsson G, Reynisdottir I et al. A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat Genet 2007;39:770-775.
17. Parra EJ, Below JE, Krithika S et al.; Diabetes Genetics Replication and Meta-analysis (DIAGRAM) Consortium. Genome-wide association study of type 2 diabetes in a sample from Mexico City and a meta-analysis of a Mexican-American sample from Starr County, Texas. Diabetologia 2011;54:2038-2046.
18. Dupuis J, Langenberg C, Prokopenko I et al.; DIAGRAM Consortium; GIANT Consortium; Global BPgen Consortium; Anders Hamsten on behalf of Procardis Consortium; MAGIC investigators. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 2010;42:105-116.
19. Saxena R, Hivert MF, Langenberg C et al.; GIANT Consortium; MAGIC investigators. Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat Genet 2010;42:142-148.
20. Florez JC, Jablonski KA, Bayley N et al.; Diabetes Prevention Program Research Group. TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N Engl J Med 2006;355:241-250.
21. Moore AF, Jablonski KA, McAteer JB et al.; Diabetes Prevention Program Research Group. Extension of type 2 diabetes genome-wide association scan results in the Diabetes Prevention Program. Diabetes 2008;57: 2503-2510.
22. Laukkanen O, Pihlajamäki J, Lindström J et al.; Finnish Diabetes Prevention Study Group. Polymorphisms of the SUR1 (ABCC8) and Kir6.2 (KCNJ11) genes predict the conversion from impaired glucose tolerance to type 2 diabetes. The Finnish Diabetes Prevention Study. J Clin Endocrinol Metab 2004;89:6286-6290.
23. Florez JC, Jablonski KA, Kahn SE et al. Type 2 diabetes-associated missense polymorphisms KCNJ11 E23K AND ABCC8 A1369S influence progression to diabetes and response to interventions in the Diabetes Prevention Program. Diabetes 2007;56:531-536.
24. Florez JC, Jablonski KA, Sun MW et al.; Diabetes Prevention Program Research Group. Effects of the type 2 diabetes-associated PPARG P12A polymorphism on progression to diabetes and response to troglitazone. J Clin Endocrinol Metab 2007;92:1502-1509.
25. Franks PW, Jablonski KA, Delahanty L et al.; Diabetes Prevention Program Research Group. The Pro12Ala variant at the peroxisome proliferatoractivated receptor γ gene and change in obesity-related traits in the Diabetes Prevention Program. Diabetologia 2007;50:2451-2460.
26. Florez JC, Jablonski KA, McAteer J et al.; Diabetes Prevention Program Research Group. Testing of diabetes-associated WFS1 polymorphisms in the Diabetes Prevention Program. Diabetologia 2008;51:451-457.
27. Pi-Sunyer X, Blackburn G, Brancati FL et al.; Look AHEAD Research Group. Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care 2007;30:1374-1383.
28. Bray G, Gregg E, Haffner S et al.; Look AHEAD Research Group. Baseline characteristics of the randomised cohort from the Look AHEAD (Action for Health in Diabetes) study. Diab Vasc Dis Res 2006;3:202-215.
29. Ryan DH, Espeland MA, Foster GD et al.; Look AHEAD Research Group. Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes. Control Clin Trials 2003;24:610-628.
30. Aiyer AN, Kip KE, Marroquin OC et al. Racial differences in coronary artery calcification are not attributed to differences in lipoprotein particle sizes: the Heart Strategies Concentrating on Risk Evaluation (Heart SCORE) Study. Am Heart J 2007;153:328-334.
31. Keating BJ, Tischfield S, Murray SS et al. Concept, design and implementation of a cardiovascular gene-centric 50 k SNP array for large-scale genomic association studies. PLoS ONE 2008;3:e3583.
32. Price AL, Patterson NJ, Plenge RM et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006;38:904-909.
33. Benjamini Y, Hochberg A. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Stat Soc 1995;57:289-300.
34. Helgason A, Pálsson S, Thorleifsson G et al. Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution. Nat Genet 2007;39:218-225.
35. Hivert MF, Jablonski KA, Perreault L et al.; DIAGRAM Consortium; Diabetes Prevention Program Research Group. Updated genetic score based on 34 confirmed type 2 diabetes Loci is associated with diabetes incidence and regression to normoglycemia in the Diabetes Prevention Program. Diabetes 2011;60:1340-1348.
36. Wing RR; Look AHEAD Research Group. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. Arch Intern Med 2010;170:1566-1575.